Zi-Rong Chen

2PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 11, 2023
Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration.

Zi-Rong Chen, Chen-Han Chueh, Nai-Jung Chiang

|Dec 27, 2022
Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy.

Chen-Han Chueh, Yi-Wen Tsai, Zi-Rong Chen

Pageof 1

Frequent Collaborators

2 joint publications

Chen-Han Chueh

2 joint publications

Yi-Wen Tsai

2 joint publications

Nai-Jung Chiang

1 joint publications

Ming-Neng Shiu